drugset / Trial / NCT07215936

Dose-dense Capecitabine Schedule [7days on _7 Days Off] in Colorectal Cancer in Comparison With Standered Regimen

NCT07215936 ↗

Phase 2 Active not recruiting 100 enrolled Sohag University
RandomizedParallel-groupOpen-labelTreatment

Summary

Dose\_dense Capecitabine Schedule in colorectal cancers

Timeline

Start
2025-09-25
Primary completion
2027-09
Completion
2028-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Capecitabine Small molecule 1000 mg/m2 —
Comparator Capecitabine Small molecule 1750 mg/m2 —

Indications